1. Institute, NC Cancer Statistics. Understanding Cancer [webpage] 2020 9/20/20 [cited 2021 9/21/21]; Available from: https://www.cancer.gov/about-cancer/understanding/statistics.
2. Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al. SEER Cancer Statistics Review, 1975–2018, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2018/, based on November 2020 SEER data submission, posted to the SEER web site, April 2021.
3. Fuller DH, Berglund P. Amplifying RNA vaccine development. N Engl J Med. 2020;382:2469–71.
4. Hu Z, Ott PA, Wu CJ. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat Rev Immunol. 2018;18:168–82.
5. Collins JM, Redman JM, Gulley JL. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy. Expert Rev Vaccines. 2018;17:697–705.